The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 101-59-87
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2024
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Kaibysheva V.O.

Pirogov Russian National Research Medical University of the Russian Ministry of Health

Kashin S.V.

Yaroslavl Regional Oncology Hospital

Karasev A.V.

Atlas LLC

Merkulova A.O.

Research Institute of Emergency Pediatric Surgery and Traumatology of the Moscow Healthcare Department

Krainova E.A.

Yaroslavl Regional Clinical Oncology Hospital

Fedorov E.D.

Pirogov Russian National Research Medical University of the Russian Ministry of Health

Shapovolyants S.G.

Pirogov Russian National Research Medical University

Update on Barrett’s esophagus diagnosis and treatment

Authors:

Kaibysheva V.O., Kashin S.V., Karasev A.V., Merkulova A.O., Krainova E.A., Fedorov E.D., Shapovolyants S.G.

More about the authors

Journal: Russian Journal of Evidence-Based Gastroenterology. 2020;9(4): 33‑54

DOI: 10.17116/dokgastro2020904133

Views: 4638

Downloaded: 309

Download PDF (RU)
Contact the author
Table of contents

To cite this article:

Kaibysheva VO, Kashin SV, Karasev AV, Merkulova AO, Krainova EA, Fedorov ED, Shapovolyants SG. Update on Barrett’s esophagus diagnosis and treatment. Russian Journal of Evidence-Based Gastroenterology. 2020;9(4):33‑54. (In Russ.)
https://doi.org/10.17116/dokgastro2020904133

Подписка 2025 (Russian Journal of Evidence-Based Gastroenterology)
МСФ на ЯМ
Close metadata
Recommended articles:
Early adenocarcinoma in Barrett’s esophagus with implantation meta­stasis. (A case report). Russian Journal of Evidence-Based Gastroenterology. 2024;(1):101-107
Anti­reflux lapa­roscopic inte­rvention. Piro­gov Russian Journal of Surgery. 2024;(9):16-21
Esophageal pathology and bronchial asthma: pathogenetic inte­ractions and possibilities for therapy opti­mization. Russian Journal of Preventive Medi­cine. 2024;(11):129-134

AIM

To present updated data on Barrett’s esophagus diagnosis and treatment.

Barrett’s esophagus is a condition that develops as a result of the stratified squamous epithelium replacement in the distal esophagus by metaplastic columnar epithelium that has intestinal features. Rising incidence and mortality from esophageal adenocarcinoma in developed countries demand urgent development of Barrett’s esophagus’ diagnostic and treatment methods.

Risk factors for the development of Barrett’s esophagus and esophageal adenocarcinoma are gastroesophageal reflux disease, obesity, male sex, age over 50 years, smoking, and family history. Recently, significant progress has been made in the development of the diagnosis of Barrett’s esophagus and esophageal adenocarcinoma and effective endoscopic treatment of dysplasia, which significantly reduces the risk of progression to adenocarcinoma.

Keywords:

esophageal adenocarcinoma
Barrett’s esophagus
GERD
narrow-band imaging with magnifying endoscopy
endoscopic resection

Authors:

Kaibysheva V.O.

Pirogov Russian National Research Medical University of the Russian Ministry of Health

Kashin S.V.

Yaroslavl Regional Oncology Hospital

Karasev A.V.

Atlas LLC

Merkulova A.O.

Research Institute of Emergency Pediatric Surgery and Traumatology of the Moscow Healthcare Department

Krainova E.A.

Yaroslavl Regional Clinical Oncology Hospital

Fedorov E.D.

Pirogov Russian National Research Medical University of the Russian Ministry of Health

Shapovolyants S.G.

Pirogov Russian National Research Medical University

Received:

15.10.2020

Accepted:

15.11.2020

List of references:

  1. Spechler SJ, Souza RF. Barrett’s esophagus. New England Journal of Medicine. 2014;371(9):836-845.  https://doi.org/10.1056/NEJMra1314704
  2. Weusten B, Bisschops R, Coron E, Dinis-Ribeiro M, Dumonceau JM, Esteban JM, Hassan C, Pech O, Repici A, Bergman J, di Pietro M. Endoscopic management of Barrett’s esophagus: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement. Endoscopy. 2017;49(2):191-198.  https://doi.org/10.1055/s-0042-122140
  3. Cameron AJ, Carpenter HA. Barrett’s esophagus, high-grade dysplasia, and early adenocarcinoma: a pathological study. American Journal of Gastroenterology. 1997;92(4):586-591. 
  4. Cameron AJ, Zinsmeister AR, Ballard DJ, Carney JA. Prevalence of columnar-lined (Barrett’s) esophagus: comparison of population-based clinical and autopsy findings. Gastroenterology. 1990;99(4):918-922.  https://doi.org/10.1016/0016-5085(90)90607-3
  5. Hur C, Miller M, Kong CY, Dowling EC, Nattinger KJ, Dunn M, Feuer EJ. Trends in esophageal adenocarcinoma incidence and mortality. Cancer. 2013;119(6):1149-1158. https://doi.org/10.1002/cncr.27834
  6. Prasad GA, Wu TT, Wigle DA, Buttar NS, Wongkeesong LM, Dunagan KT, Lutzke LS, Borkenhagen LS, Wang KK. Endoscopic and surgical treatment of mucosal (T1a) esophageal adenocarcinoma in Barrett’s esophagus. Gastroenterology. 2009;137(3):815-823.  https://doi.org/10.1053/j.gastro.2009.05.059
  7. Shaheen NJ, Sharma P, Overholt BF, Wolfsen HC, Sampliner RE, Wang KK, Galanko JA, Bronner MP, Goldblum JR, Bennett AE, Jobe BA, Eisen GM, Fennerty MB, Hunter JG, Fleischer DE, Sharma VK, Hawes RH, Hoffman BJ, Rothstein RI, Gordon SR, Mashimo H, Chang KJ, Muthusamy VR, Edmundowicz SA, Spechler SJ, Siddiqui AA, Souza RF, Infantolino A, Falk GW, Kimmey MB, Madanick RD, Chak A, Lightdale CJ. Radiofrequency ablation in Barrett’s esophagus with dysplasia. New England Journal of Medicine. 2009;360(22):2277-2288. https://doi.org/10.1056/NEJMoa0808145
  8. Phoa KN, van Vilsteren FG, Weusten BL, Bisschops R, Schoon EJ, Ragunath K, Fullarton G, Di Pietro M, Ravi N, Visser M, Offerhaus GJ, Seldenrijk CA, Meijer SL, ten Kate FJ, Tijssen JG, Bergman JJ. Radiofrequency ablation vs endoscopic surveillance for patients with Barrett esophagus and low-grade dysplasia: a randomized clinical trial. JAMA. 2014;311(12):1209-1217. https://doi.org/10.1001/jama.2014.2511
  9. Ivashkin VT, Maev IV, Trukhmanov AS, Sokolov VV, Pirogov SS, Zairat’yants OV, Sheptulin AA, Lapina TL, Zairat’yants GO, Kaibysheva VO. Profil’naya komissiya RGA po spetsial’nosti «Gastroenterologiya» Ministerstva zdravookhraneniya Rossijskoj Federatsii. Rossijskaya gastroenterologicheskaya assotsiatsiya. Pishchevod Barretta. Klinicheskie rekomendatsii. M. 2014. Accessed November 10, 2020. (In Russ.).
  10. Bhat S, Coleman HG, Yousef F, Johnston BT, McManus DT, Gavin AT, Murray LJ. Risk of malignant progression in Barrett’s esophagus patients: results from a large population-based study. Journal of the National Cancer Institute. 2011;103(13):1049-1057. https://doi.org/10.1093/jnci/djr203
  11. Sharma P, Dent J, Armstrong D, Bergman JJ, Gossner L, Hoshihara Y, Jankowski JA, Junghard O, Lundell L, Tytgat GN, Vieth M. The development and validation of an endoscopic grading system for Barrett’s esophagus: the Prague C&M criteria. Gastroenterology. 2006;131(5):1392-1399. https://doi.org/10.1053/j.gastro.2006.08.032
  12. Jung KW, Talley NJ, Romero Y, Katzka DA, Schleck CD, Zinsmeister AR, Dunagan KT, Lutzke LS, Wu TT, Wang KK, Frederickson M, Geno DM, Locke GR, Prasad GA. Epidemiology and natural history of intestinal metaplasia of the gastroesophageal junction and Barrett’s esophagus: a population-based study. American Journal of Gastroenterology. 2011;106(8):1447-1456. https://doi.org/10.1038/ajg.2011.130
  13. Thota PN, Vennalaganti P, Vennelaganti S, Young P, Gaddam S, Gupta N, Lieberman D, Sampliner R, Falk GW, Mathur S, Kennedy K, Cash BD, Moawad F, Bansal A, Spaander MC, Bruno MJ, Vargo J, Sharma P. Low Risk of High-Grade Dysplasia or Esophageal Adenocarcinoma Among Patients With Barrett’s Esophagus Less Than 1 cm (Irregular Z Line) Within 5 Years of Index Endoscopy. Gastroenterology. 2017;152(5):987-992.  https://doi.org/10.1053/j.gastro.2016.12.005
  14. Ganz RA, Allen JI, Leon S, Batts KP. Barrett’s esophagus is frequently overdiagnosed in clinical practice: results of the Barrett’s Esophagus Endoscopic Revision (BEER) study. Gastrointestinal Endoscopy. 2014;79(4):565-573.  https://doi.org/10.1016/j.gie.2013.09.024
  15. Ronkainen J, Aro P, Storskrubb T, Johansson SE, Lind T, Bolling-Sternevald E, Vieth M, Stolte M, Talley NJ, Agréus L. Prevalence of Barrett’s esophagus in the general population: an endoscopic study. Gastroenterology. 2005;129(6):1825-1831. https://doi.org/10.1053/j.gastro.2005.08.053
  16. Zagari RM, Fuccio L, Wallander MA, Johansson S, Fiocca R, Casanova S, Farahmand BY, Winchester CC, Roda E, Bazzoli F. Gastro-oesophageal reflux symptoms, oesophagitis and Barrett’s oesophagus in the general population: the Loiano-Monghidoro study. Gut. 2008;57(10):1354-1359. https://doi.org/10.1136/gut.2007.145177
  17. Sami SS, Dunagan KT, Johnson ML, Schleck CD, Shah ND, Zinsmeister AR, Wongkeesong LM, Wang KK, Katzka DA, Ragunath K, Iyer PG. A randomized comparative effectiveness trial of novel endoscopic techniques and approaches for Barrett’s esophagus screening in the community. American Journal of Gastroenterology. 2015;110(1):148-158.  https://doi.org/10.1038/ajg.2014.362
  18. Gerson LB, Shetler K, Triadafilopoulos G. Prevalence of Barrett’s esophagus in asymptomatic individuals. Gastroenterology. 2002;123(2):461-467.  https://doi.org/10.1053/gast.2002.34748
  19. Singh S, Sharma AN, Murad MH, Buttar NS, El-Serag HB, Katzka DA, Iyer PG. Central adiposity is associated with increased risk of esophageal inflammation, metaplasia, and adenocarcinoma: a systematic review and meta-analysis. Clinical Gastroenterology and Hepatology. 2013;11(11):1399-1412.e7.  https://doi.org/10.1016/j.cgh.2013.05.009
  20. Orloff M, Peterson C, He X, Ganapathi S, Heald B, Yang YR, Bebek G, Romigh T, Song JH, Wu W, David S, Cheng Y, Meltzer SJ, Eng C. Germline mutations in MSR1, ASCC1, and CTHRC1 in patients with Barrett esophagus and esophageal adenocarcinoma. JAMA. 2011;306(4):410-419.  https://doi.org/10.1001/jama.2011.1029
  21. Gharahkhani P, Fitzgerald RC, Vaughan TL, Palles C, Gockel I, Tomlinson I, Buas MF, May A, Gerges C, Anders M, Becker J, Kreuser N, Noder T, Venerito M, Veits L, Schmidt T, Manner H, Schmidt C, Hess T, Böhmer AC, Izbicki JR, Hölscher AH, Lang H, Lorenz D, Schumacher B, Hackelsberger A, Mayershofer R, Pech O, Vashist Y, Ott K, Vieth M, Weismüller J, Nöthen MM; Barrett’s and Esophageal Adenocarcinoma Consortium (BEACON); Esophageal Adenocarcinoma GenEtics Consortium (EAGLE); Wellcome Trust Case Control Consortium 2 (WTCCC2), Attwood S, Barr H, Chegwidden L, de Caestecker J, Harrison R, Love SB, MacDonald D, Moayyedi P, Prenen H, Watson RGP, Iyer PG, Anderson LA, Bernstein L, Chow WH, Hardie LJ, Lagergren J, Liu G, Risch HA, Wu AH, Ye W, Bird NC, Shaheen NJ, Gammon MD, Corley DA, Caldas C, Moebus S, Knapp M, Peters WHM, Neuhaus H, Rösch T, Ell C, MacGregor S, Pharoah P, Whiteman DC, Jankowski J, Schumacher J. Genome-wide association studies in oesophageal adenocarcinoma and Barrett’s oesophagus: a large-scale meta-analysis. Lancet. Oncology. 2016;17(10):1363-1373. https://doi.org/10.1016/S1470-2045(16)30240-6
  22. Anderson LA, Cantwell MM, Watson RG, Johnston BT, Murphy SJ, Ferguson HR, McGuigan J, Comber H, Reynolds JV, Murray LJ. The association between alcohol and reflux esophagitis, Barrett’s esophagus, and esophageal adenocarcinoma. Gastroenterology. 2009;136(3):799-805.  https://doi.org/10.1053/j.gastro.2008.12.005
  23. Wang Z, Shaheen NJ, Whiteman DC, Anderson LA, Vaughan TL, Corley DA, El-Serag HB, Rubenstein JH, Thrift AP. Helicobacter pylori Infection Is Associated With Reduced Risk of Barrett’s Esophagus: An Analysis of the Barrett’s and Esophageal Adenocarcinoma Consortium. American Journal of Gastroenterology. 2018;113(8):1148-1155. https://doi.org/10.1038/s41395-018-0070-3
  24. Lopetuso LR, Severgnini M, Pecere S, Ponziani FR, Boskoski I, Larghi A, Quaranta G, Masucci L, Ianiro G, Camboni T, Gasbarrini A, Costamagna G, Consolandi C, Cammarota G. Esophageal microbiome signature in patients with Barrett’s esophagus and esophageal adenocarcinoma. PLoS One. 2020;15(5):e0231789. https://doi.org/10.1371/journal.pone.0231789
  25. Benaglia T, Sharples LD, Fitzgerald RC, Lyratzopoulos G. Health benefits and cost effectiveness of endoscopic and nonendoscopic cytosponge screening for Barrett’s esophagus. Gastroenterology. 2013;144(1):62-73.e6.  https://doi.org/10.1053/j.gastro.2012.09.060
  26. Shaheen NJ, Falk GW, Iyer PG, Gerson LB; American College of Gastroenterology. ACG Clinical Guideline: Diagnosis and Management of Barrett’s Esophagus. American Journal of Gastroenterology. 2016;111(1):30-51.  https://doi.org/10.1038/ajg.2015.322
  27. Fitzgerald RC, di Pietro M, Ragunath K, Ang Y, Kang JY, Watson P, Trudgill N, Patel P, Kaye PV, Sanders S, O’Donovan M, Bird-Lieberman E, Bhandari P, Jankowski JA, Attwood S, Parsons SL, Loft D, Lagergren J, Moayyedi P, Lyratzopoulos G, de Caestecker J; British Society of Gastroenterology. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett’s oesophagus. Gut. 2014;63(1):7-42.  https://doi.org/10.1136/gutjnl-2013-305372
  28. Spechler SJ, Sharma P, Souza RF, Inadomi JM, Shaheen NJ; American Gastroenterological Association. American Gastroenterological Association technical review on the management of Barrett’s esophagus. Gastroenterology. 2011;140(3):e18-e13.  https://doi.org/10.1053/j.gastro.2011.01.031
  29. Atkinson M, Das A, Faulx A, Kinnard M, Falck-Ytter Y, Chak A. Ultrathin esophagoscopy in screening for Barrett’s esophagus at a Veterans Administration Hospital: easy access does not lead to referrals. American Journal of Gastroenterology. 2008;103(1):92-97.  https://doi.org/10.1111/j.1572-0241.2007.01501.x
  30. Ross-Innes CS, Debiram-Beecham I, O’Donovan M, Walker E, Varghese S, Lao-Sirieix P, Lovat L, Griffin M, Ragunath K, Haidry R, Sami SS, Kaye P, Novelli M, Disep B, Ostler R, Aigret B, North BV, Bhandari P, Haycock A, Morris D, Attwood S, Dhar A, Rees C, Rutter MD, Sasieni PD, Fitzgerald RC; BEST2 Study Group. Evaluation of a minimally invasive cell sampling device coupled with assessment of trefoil factor 3 expression for diagnosing Barrett’s esophagus: a multi-center case-control study. PLoS Med. 2015;12(1):e1001780. https://doi.org/10.1371/journal.pmed.1001780
  31. Sami SS, Subramanian V, Ortiz-Fernández-Sordo J, Saeed A, Singh S, Guha IN, Iyer PG, Ragunath K. Performance characteristics of unsedated ultrathin video endoscopy in the assessment of the upper GI tract: systematic review and meta-analysis. Gastrointestinal Endoscopy. 2015;82(5):782-792.  https://doi.org/10.1016/j.gie.2015.07.016
  32. Iyer PG, Taylor WR, Johnson ML, Lansing RL, Maixner KA, Yab TC, Simonson JA, Devens ME, Slettedahl SW, Mahoney DW, Berger CK, Foote PH, Smyrk TC, Wang KK, Wolfsen HC, Ahlquist DA. Highly Discriminant Methylated DNA Markers for the Non-endoscopic Detection of Barrett’s Esophagus. American Journal of Gastroenterology. 2018;113(8):1156-1166. https://doi.org/10.1038/s41395-018-0107-7
  33. Rubenstein JH, Morgenstern H, Appelman H, Scheiman J, Schoenfeld P, McMahon LF Jr, Metko V, Near E, Kellenberg J, Kalish T, Inadomi JM. Prediction of Barrett’s esophagus among men. American Journal of Gastroenterology. 2013;108(3):353-362.  https://doi.org/10.1038/ajg.2012.446
  34. Amadi C, Gatenby P. Barrett’s oesophagus: Current controversies. World Journal of Gastroenterology. 2017;23(28):5051-5067. https://doi.org/10.3748/wjg.v23.i28.5051
  35. Clermont M, Falk GW. Clinical Guidelines Update on the Diagnosis and Management of Barrett’s Esophagus. Digestive Diseases and Sciences. 2018;63(8):2122-2128. https://doi.org/10.1007/s10620-018-5070-z
  36. Lagergren J, Bergström R, Lindgren A, Nyrén O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. New England Journal of Medicine. 1999;340(11):825-831.  https://doi.org/10.1056/NEJM199903183401101
  37. Sawas T, Killcoyne S, Iyer PG, Wang KK, Smyrk TC, Kisiel JB, Qin Y, Ahlquist DA, Rustgi AK, Costa RJ, Gerstung M, Fitzgerald RC, Katzka DA; OCCAMS Consortium. Identification of Prognostic Phenotypes of Esophageal Adenocarcinoma in 2 Independent Cohorts. Gastroenterology. 2018;155(6):1720-1728.e4.  https://doi.org/10.1053/j.gastro.2018.08.036
  38. Singh S, Garg SK, Singh PP, Iyer PG, El-Serag HB. Acid-suppressive medications and risk of oesophageal adenocarcinoma in patients with Barrett’s oesophagus: a systematic review and meta-analysis. Gut. 2014;63(8):1229-1237. https://doi.org/10.1136/gutjnl-2013-305997
  39. Nikonov EL, Kashin SV, Vidyaeva NS, Krainova EA. Barrett’s oesophagus: the modern approaches to diagnostics, therapy, and reduction of the risk of cancer development. Dokazatel’naya gastroenterologiya. 2017;6(4):4-19. (In Russ.). https://doi.org/10.17116/dokgastro2017644-19
  40. Kashin SV, Vidyaeva NS, Kuvaev RO, Krainova EA, Haidri R, Ragunat K, Manner H. The treatment of the patients presenting with Barrett’s oesophagus. Dokazatel’naya gastroenterologiya. 2017;6(4):59-77. (In Russ.). https://doi.org/10.17116/dokgastro20176459-77
  41. Kaibysheva VO, Shapoval’yants SG. The role of functional study methods in diagnostics and the choice of treatment of gastroesophageal reflux disease and its complications. Dokazatel’naya gastroenterologiya. 2017;6(3):9-18. (In Russ). https://doi.org/10.17116/dokgastro2017639-18
  42. Kaibysheva VO, Morozov SV, Isakov VA, Shapoval’yants SG. The role of high resolution esophageal manometry in the diagnosis of gastroesophageal reflux disease. Eksperimental’naya i klinicheskaya gastroenterologiya. 2018;10(158):10-21. (In Russ.).
  43. Ribolsi M, Balestrieri P, Emerenziani S, Guarino MP, Cicala M. Weak peristalsis with large breaks is associated with higher acid exposure and delayed reflux clearance in the supine position in GERD patients. American Journal of Gastroenterology. 2014;109(1):46-51.  https://doi.org/10.1038/ajg.2013.373
  44. Savarino E, Gemignani L, Pohl D, Zentilin P, Dulbecco P, Assandri L, Marabotto E, Bonfanti D, Inferrera S, Fazio V, Malesci A, Tutuian R, Savarino V. Oesophageal motility and bolus transit abnormalities increase in parallel with the severity of gastro-oesophageal reflux disease. Alimentary Pharmacology & Therapeutics. 2011;34(4):476-486.  https://doi.org/10.1111/j.1365-2036.2011.04742.x
  45. Ribolsi M, Balestrieri P, Biasutto D, Emerenziani S, Cicala M. Role of mixed reflux and hypomotility with delayed reflux clearance in patients with non-cardiac chest pain. Journal of Neurogastroenterology and Motility. 2016;22(4):606-612.  https://doi.org/10.5056/jnm15182
  46. Wykypiel H, Hugl B, Gadenstaetter M, Bonatti H, Bodner J, Wetscher GJ. Laparoscopic partial posterior (Toupet) fundoplication improves esophageal bolus propagation on scintigraphy. Surgical Endoscopy. 2008;22(8):1845-1851. https://doi.org/10.1007/s00464-007-9719-5
  47. Strate U, Emmermann A, Fibbe C, Layer P, Zornig C. Laparoscopic fundoplication: Nissen versus Toupet two-year outcome of a prospective randomized study of 200 patients regarding preoperative esophageal motility. Surgical Endoscopy. 2008;22(1):21-30.  https://doi.org/10.1007/s00464-007-9546-8
  48. Maradey-Romero C, Gabbard S, Fass R. Treatment of esophageal motility disorders based on the Chicago Classification. Current Treatment Options in Gastroenterology. 2014;12(4):441-455.  https://doi.org/10.1007/s11938-014-0032-9
  49. Kaltenbach T, Crockett S, Gerson LB. Are lifestyle measures effective in patients with gastroesophageal reflux disease? An evidence-based approach. Archives of Internal Medicine. 2006;166(9):965-971.  https://doi.org/10.1001/archinte.166.9.965
  50. Blonski W, Vela MF, Freeman J, Sharma N, Castell DO. The effect of oral buspirone, pyridostigmine, and bethanechol on esophageal function evaluated with combined multichannel esophageal impedance-manometry in healthy volunteers. Journal of Clinical Gastroenterology. 2009;43(3):253-260.  https://doi.org/10.1097/MCG.0b013e318167b89d
  51. Johnson DA, Drane WE, Curran J, Benjamin SB, Chobanian SJ, Karvelis K, Cattau EL Jr. Metoclopramide response in patients with progressive systemic sclerosis. Effect on esophageal and gastric motility abnormalities. Archives of Internal Medicine. 1987;147(9):1597-1601.
  52. Chrysos E, Tzovaras G, Epanomeritakis E, Tsiaoussis J, Vrachasotakis N, Vassilakis JS, Xynos E. Erythromycin enhances oesophageal motility in patients with gastro-oesophageal reflux. ANZ Journal of Surgery. 2001;71(2):98-102.  https://doi.org/10.1046/j.1440-1622.2001.02005.x
  53. Chang CT, Shiau YC, Lin CC, Li TC, Lee CC, Kao CH. Improvement of esophageal and gastric motility after 2-week treatment of oral erythromycin in patients with non-insulin-dependent diabetes mellitus. Journal of Diabetes and Its Complications. 2003;17(3): 141-144.  https://doi.org/10.1016/s1056-8727(02)00168-x
  54. Staiano A, Clouse RE. The effects of cisapride on the topography of oesophageal peristalsis. Alimentary Pharmacology and Therapeutics. 1996;10(6):875-882.  https://doi.org/10.1046/j.1365-2036.1996.94266000.x
  55. Fox M, Menne D, Stutz B, Fried M, Schwizer W. The effects of tegaserod on oesophageal function and bolus transport in healthy volunteers: studies using concurrent high-resolution manometry and videofluoroscopy. Alimentary Pharmacology and Therapeutics. 2006;24(7):1017-1027. https://doi.org/10.1111/j.1365-2036.2006.03090.x
  56. Scarpellini E, Vos R, Blondeau K, Boecxstaens V, Farré R, Gasbarrini A, Tack J. The effects of itopride on oesophageal motility and lower oesophageal sphincter function in man. Alimentary Pharmacology and Therapeutics. 2011;33(1):99-105.  https://doi.org/10.1111/j.1365-2036.2010.04487.x
  57. Kessing BF, Smout AJ, Bennink RJ, Kraaijpoel N, Oors JM, Bredenoord AJ. Prucalopride decreases esophageal acid exposure and accelerates gastric emptying in healthy subjects. Neurogastroenterology and Motility. 2014;26(8):1079-1086. https://doi.org/10.1111/nmo.12359
  58. Zerbib F, Roman S. Current Therapeutic Options for Esophageal Motor Disorders as Defined by the Chicago Classification. Journal of Clinical Gastroenterology. 2015;49(6):451-460.  https://doi.org/10.1097/MCG.0000000000000317
  59. DeMeester SR, DeMeester TR. Columnar mucosa and intestinal metaplasia of the esophagus: fifty years of controversy. Annals of Surgery. 2000;231(3):303-321.  https://doi.org/10.1097/00000658-200003000-00003
  60. Ye W, Chow WH, Lagergren J, Yin L, Nyrén O. Risk of adenocarcinomas of the esophagus and gastric cardia in patients with gastroesophageal reflux diseases and after antireflux surgery. Gastroenterology. 2001;121(6):1286-1293. https://doi.org/10.1053/gast.2001.29569
  61. Tran T, Spechler SJ, Richardson P, El-Serag HB. Fundoplication and the risk of esophageal cancer in gastroesophageal reflux disease: a Veterans Affairs cohort study. American Journal of Gastroenterology. 2005;100(5):1002-1008. https://doi.org/10.1111/j.1572-0241.2005.41007.x
  62. Corey KE, Schmitz SM, Shaheen NJ. Does a surgical antireflux procedure decrease the incidence of esophageal adenocarcinoma in Barrett’s esophagus? A meta-analysis. American Journal of Gastroenterology. 2003;98(11):2390-2394. https://doi.org/10.1111/j.1572-0241.2003.08702.x
  63. Chang EY, Morris CD, Seltman AK, O’Rourke RW, Chan BK, Hunter JG, Jobe BA. The effect of antireflux surgery on esophageal carcinogenesis in patients with barrett esophagus: a systematic review. Annals of Surgery. 2007;246(1):11-21.  https://doi.org/10.1097/01.sla.0000261459.10565.e9
  64. Bhandari P. Acetic Acid Chromoendoscopy in the Setting of Neoplastic Barrett Esophagus. Gastroenterology and Hepatology. 2017;13(8):508-510. 
  65. Qumseya BJ, Wang H, Badie N, Uzomba RN, Parasa S, White DL, Wolfsen H, Sharma P, Wallace MB. Advanced imaging technologies increase detection of dysplasia and neoplasia in patients with Barrett’s esophagus: a meta-analysis and systematic review. Clinical Gastroenterology and Hepatology. 2013;11(12):1562-70.e702. https://doi.org/10.1016/j.cgh.2013.06.017
  66. Vennalaganti PR, Kaul V, Wang KK, Falk GW, Shaheen NJ, Infantolino A, Johnson DA, Eisen G, Gerson LB, Smith MS, Iyer PG, Lightdale CJ, Schnoll-Sussman F, Gupta N, Gross SA, Abrams J, Haber GB, Chuttani R, Pleskow DK, Kothari S, Goldblum JR, Zhang Y, Sharma P. Increased detection of Barrett’s esophagus-associated neoplasia using wide-area trans-epithelial sampling: a multicenter, prospective, randomized trial. Gastrointestinal Endoscopy. 2018;87(2):348-355.  https://doi.org/10.1016/j.gie.2017.07.039
  67. Desai TK, Krishnan K, Samala N, Singh J, Cluley J, Perla S, Howden CW. The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett’s oesophagus: a meta-analysis. Gut. 2012;61(7):970-976.  https://doi.org/10.1136/gutjnl-2011-300730
  68. Hvid-Jensen F, Pedersen L, Funch-Jensen P, Drewes AM. Proton pump inhibitor use may not prevent high-grade dysplasia and oesophageal adenocarcinoma in Barrett’s oesophagus: a nationwide study of 9883 patients. Alimentary Pharmacology and Therapeutics. 2014;39(9):984-991.  https://doi.org/10.1111/apt.12693
  69. Singh S, Manickam P, Amin AV, Samala N, Schouten LJ, Iyer PG, Desai TK. Incidence of esophageal adenocarcinoma in Barrett’s esophagus with low-grade dysplasia: a systematic review and meta-analysis. Gastrointestinal Endoscopy. 2014;79(6):897-983.e3.  https://doi.org/10.1016/j.gie.2014.01.009
  70. Rastogi A, Puli S, El-Serag HB, Bansal A, Wani S, Sharma P. Incidence of esophageal adenocarcinoma in patients with Barrett’s esophagus and high-grade dysplasia: a meta-analysis. Gastrointestinal Endoscopy. 2008;67(3):394-398.  https://doi.org/10.1016/j.gie.2007.07.019
  71. Wani S. Population-based estimates of cancer and mortality in Barrett’s esophagus: implications for the future. Clinical Gastroenterology and Hepatology. 2011;9(9):723-724.  https://doi.org/10.1016/j.cgh.2011.05.025
  72. Small AJ, Araujo JL, Leggett CL, Mendelson AH, Agarwalla A, Abrams JA, Lightdale CJ, Wang TC, Iyer PG, Wang KK, Rustgi AK, Ginsberg GG, Forde KA, Gimotty PA, Lewis JD, Falk GW, Bewtra M. Radiofrequency Ablation Is Associated With Decreased Neoplastic Progression in Patients with Barrett’s Esophagus and Confirmed Low-Grade Dysplasia. Gastroenterology. 2015;149(3):567-e14.  https://doi.org/10.1053/j.gastro.2015.04.013
  73. Qumseya BJ, Wani S, Gendy S, Harnke B, Bergman JJ, Wolfsen H. Disease Progression in Barrett’s Low-Grade Dysplasia with Radiofrequency Ablation Compared with Surveillance: Systematic Review and Meta-Analysis. American Journal of Gastroenterology. 2017;112(6):849-865.  https://doi.org/10.1038/ajg.2017.70
  74. Abrams JA, Kapel RC, Lindberg GM, Saboorian MH, Genta RM, Neugut AI, Lightdale CJ. Adherence to biopsy guidelines for Barrett’s esophagus surveillance in the community setting in the United States. Clinical Gastroenterology and Hepatology. 2009;7(7):736-710.  https://doi.org/10.1016/j.cgh.2008.12.027
  75. Visrodia K, Singh S, Krishnamoorthi R, Ahlquist DA, Wang KK, Iyer PG, Katzka DA. Magnitude of Missed Esophageal Adenocarcinoma after Barrett’s Esophagus Diagnosis: A Systematic Review and Meta-analysis. Gastroenterology. 2016;150(3):599-e15.  https://doi.org/10.1053/j.gastro.2015.11.040
  76. Montgomery E, Bronner MP, Goldblum JR, Greenson JK, Haber MM, Hart J, Lamps LW, Lauwers GY, Lazenby AJ, Lewin DN, Robert ME, Toledano AY, Shyr Y, Washington K. Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. Human Pathology. 2001;32(4):368-378.  https://doi.org/10.1053/hupa.2001.23510
  77. Codipilly DC, Chandar AK, Singh S, Wani S, Shaheen NJ, Inadomi JM, Chak A, Iyer PG. The Effect of Endoscopic Surveillance in Patients with Barrett’s Esophagus: A Systematic Review and Meta-analysis. Gastroenterology. 2018;154(8):2068-2086.e5.  https://doi.org/10.1053/j.gastro.2018.02.022
  78. Krishnamoorthi R, Singh S, Ragunathan K, Visrodia K, Wang KK, Katzka DA, Iyer PG. Factors Associated With Progression of Barrett’s Esophagus: A Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology. 2018;16(7):1046-1055.e8.  https://doi.org/10.1016/j.cgh.2017.11.044
  79. Parasa S, Vennalaganti S, Gaddam S, Vennalaganti P, Young P, Gupta N, Thota P, Cash B, Mathur S, Sampliner R, Moawad F, Lieberman D, Bansal A, Kennedy KF, Vargo J, Falk G, Spaander M, Bruno M, Sharma P. Development and Validation of a Model to Determine Risk of Progression of Barrett’s Esophagus to Neoplasia. Gastroenterology. 2018 Apr;154(5):1282-1289.e2.  https://doi.org/10.1053/j.gastro.2017.12.009
  80. Wani S, Mathur SC, Curvers WL, Singh V, Alvarez Herrero L, Hall SB, Ulusarac O, Cherian R, McGregor DH, Bansal A, Rastogi A, Ahmed B, Singh M, Gaddam S, Ten Kate FJ, Bergman J, Sharma P. Greater interobserver agreement by endoscopic mucosal resection than biopsy samples in Barrett’s dysplasia. Clinical Gastroenterology and Hepatology. 2010;8(9):783-788.  https://doi.org/10.1016/j.cgh.2010.04.028
  81. Prasad GA, Buttar NS, Wongkeesong LM, Lewis JT, Sanderson SO, Lutzke LS, Borkenhagen LS, Wang KK. Significance of neoplastic involvement of margins obtained by endoscopic mucosal resection in Barrett’s esophagus. American Journal of Gastroenterology. 2007;102(11):2380-2386. https://doi.org/10.1111/j.1572-0241.2007.01419.x
  82. Terheggen G, Horn EM, Vieth M, Gabbert H, Enderle M, Neugebauer A, Schumacher B, Neuhaus H. A randomised trial of endoscopic submucosal dissection versus endoscopic mucosal resection for early Barrett’s neoplasia. Gut. 2017;66(5):783-793.  https://doi.org/10.1136/gutjnl-2015-310126
  83. Tomizawa Y, Iyer PG, Wong Kee Song LM, Buttar NS, Lutzke LS, Wang KK. Safety of endoscopic mucosal resection for Barrett’s esophagus. American Journal of Gastroenterology. 2013;108(9): 1440-1448. https://doi.org/10.1038/ajg.2013.187
  84. Manner H, May A, Pech O, Gossner L, Rabenstein T, Günter E, Vieth M, Stolte M, Ell C. Early Barrett’s carcinoma with «low-risk» submucosal invasion: long-term results of endoscopic resection with a curative intent. American Journal of Gastroenterology. 2008;103(10):2589-2597. https://doi.org/10.1111/j.1572-0241.2008.02083.x
  85. Eluri S, Shaheen NJ. Barrett’s esophagus: diagnosis and management. Gastrointestinal Endoscopy. 2017;85(5):889-903.  https://doi.org/10.1016/j.gie.2017.01.007
  86. Canto MI, Shaheen NJ, Almario JA, Voltaggio L, Montgomery E, Lightdale CJ. Multifocal nitrous oxide cryoballoon ablation with or without EMR for treatment of neoplastic Barrett’s esophagus (with video). Gastrointestinal Endoscopy. 2018;88(3):438-446.e2.  https://doi.org/10.1016/j.gie.2018.03.024
  87. Visrodia K, Zakko L, Singh S, Leggett CL, Iyer PG, Wang KK. Cryotherapy for persistent Barrett’s esophagus after radiofrequency ablation: a systematic review and meta-analysis. Gastrointestinal Endoscopy. 2018;87(6):1396-1404.e1.  https://doi.org/10.1016/j.gie.2018.02.021
  88. Ivashkin VT, Maev IV, Trukhmanov AS, Lapina TL, Storonova OA, Zayratyants OV, Dronova OB, Kucheryavyy YuA, Pirogov SS, Sayfutdinov RG, Uspenskiy YuP, Sheptulin AA, Andreev DN, Rumyantseva DE. Recommendations of the Russian Gastroenterological Association in Diagnosis and Treatment of Gastroesophageal Reflux Disease. Rossijskij zhurnal gastroenterologii, gepatologii, koloproktologii. 2020;30(4):70-97. (In Russ.). https://doi.org/10.22416/1382-4376-2020-30-4-70-97

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register


We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.